Sunday, August 19, 2018
 
 
Company News: Page (1) of 1 - 02/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Reprocessed Medical Devices Market worth over $3 billion by 2024: Global Market Insights, Inc.

(February 12, 2018)

Sellbyville, Delaware, Feb. 12, 2018 (GLOBE NEWSWIRE) --

Global Reprocessed Medical Devices Market is projected to surpass USD 3 billion by 2024; according to a new research report by Global Market Insights. Rising prevalence of chronic diseases that further lead to upsurge in surgical procedures drives reprocessed medical devices market size during the forecast timeframe. The increasing demand for cost cutting procedures in healthcare in developed as well as developing countries similarly upsurges need for usage of reprocessed medical devices thereby, propelling business growth. To reprocess the devices aspects such as, lifecycle, efficacy, probable risk to patient and the components used for manufacturing are taken into consideration. Reprocessing of medical devices requires to comply with authenticated procedure that will render its suitability for usage.

 The growing healthcare cost coupled with excessive prices of purchasing new medical devices creates requirement and demand for reprocessed medical devices this stimulates progress and development for reprocessing during the forecast timeframe. Moreover, the low price of reprocessed devices is foremost influence that encourages preference over new medical devices and is accountable for the increasing demand of reprocessed medical devices.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/477

Browse key industry insights spread across 120 pages with 64 market data tables & 9 figures & charts from the report, “Reprocessed Medical Devices Market” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/reprocessed-medical-devices-market

Constant corrosion of ecological surroundings owing to growing landfills can be reduced with help of reprocessed medical devices, such factors boost the industry growth in coming years. However, the major factor that hinders reprocessed medical devices market growth is related risks of surgical site infections with reprocessed devices.

 Cardiovascular medical devices held maximum revenue share of the overall reprocessed medical devices market due to high prevalence of cardiovascular diseases and, associated high surgical procedures of heart. Moreover, increasing factors such as, lack of physical exercise, unhealthy eating habits upsurges risk of cardiovascular diseases thereby, offering immense scope of growth in future for reprocessed cardiac devices.

 Hospitals accounted for largest revenue share due to increasing requirement for reprocessed medical devices that aid in medical waste management. In addition to huge wastage produced from the operating rooms requires reduction of medical waste and management of landfills every year, this can be achieved through reprocessing. Furthermore, high number of surgical procedures performed in hospitals propels reprocessed medical devices market growth.

 U.S. held substantial revenue share owing to rising prevalence of heart disease, supportive regulatory framework, high number of medical products producers involved in the reprocessing programs. Moreover, encouraging governing policies along with established healthcare infrastructure upsurges reprocessed medical devices market growth during the forecast period. According to, Centers for Disease Control & Prevention (CDC) statistics updated in November 2017, nearly half of Americans have three risk factors of heart disease, these include high cholesterol, smoking, and high blood pressure.

China and India are anticipated to grow lucratively due to increasing investments in healthcare setup by major players along with high incidences of chronic conditions such as, cardiovascular diseases that leads to cardiac surgeries. In addition, strengthening network of distributors in developing nations stimulates reprocessed medical devices market growth.

 Companies operational in the reprocessed medical devices includes Stryker Sustainability, Vanguard, GE Healthcare, Vascular Solutions, SureTek Medical, Centurion Medical Products, Soma Technology, Hygia Health Services, Steril Med (Ethicon Endo-Surgery), Mediline ReNewal, Midwest Reprocessing Centre, Medtronic, ReNu Medical, Pioneer Medical Devices, Steripro Canada, and Siemens Healthcare.

Prominent players are merging their business positions by focusing on managing Regulated Medical Waste (RMW) from landfills as well as reducing costs by adopting reprocessing and thereby, increasing business revenues. Furthermore, industry players gain tremendous benefits from reprocessing programs thereby, stimulating industry growth. For instance, in 2016, Stryker’s program for reprocessing assisted health systems to save approximately 299 USD million by eliminating 12.9 USD million pounds medical waste from the landfills.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/477

Browse Related Reports:

  • Apheresis Equipment Market Size 2016 – 2024

Apheresis Equipment Market share was USD 1.7 billion in 2015, with 11.4% CAGR estimation from 2016 to 2024. Rising prevalence of chronic diseases, growing number of platelet donors and increasing R&D investments from biopharmaceutical companies will drive global apheresis equipment market trends.

https://www.gminsights.com/industry-analysis/apheresis-equipment-market 

  • Neurovascular Devices Market Size 2016 – 2024

Neurovascular Devices Market size was valued at over USD 1.6 billion in 2015 and will exceed USD 2.3 billion by 2024 at 4.1% CAGR from 2016 to 2024 driven by primarily driven by high prevalence of brain aneurysm and ischemic strokes, rising demand for minimally invasive surgical procedures, ongoing government initiatives to modernize healthcare infrastructure etc.https://www.gminsights.com/industry-analysis/neurovascular-devices-market

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde


Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: [email protected]
Web: https://www.gminsights.com
Blog: https://www.gminsights.com/blogs
Connect with us: Facebook | Google+ | LinkedIn | Twitter


Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   itbusinessnet.com ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

    Cancer
  • Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines